The role of serum acsl4 in differentiating early-stage breast cancer
Serum ACSL4 levels were significantly lower in early-stage breast cancer patients and might serve as a useful serum indicator to support diagnosis. These findings suggested the potential clinical relevance of ACSL4 in breast cancer and highlighted the need for further studies to validate its diagnostic and prognostic value.
Authors
- Ying He (ORCID: https://orcid.org/0000-0002-3999-2655)
- Qiang Liu (ORCID: https://orcid.org/0009-0003-9286-7399)
- Nengbin Wan
- Yi Zhang (ORCID: https://orcid.org/0009-0005-9463-1384)
- Li Li (ORCID: https://orcid.org/0000-0001-6545-858X)
- Xiao He
Institutions
- Central South University (CN)
- Hunan Cancer Hospital (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-11-25
- DOI
- https://doi.org/10.1186/s40001-025-03430-5
- Citations
- 1
- Primary Topic
- Cell Adhesion Molecules Research
- Type
- article
- Field-Weighted Citation Impact
- 1.62